Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|December 4, 2014
From work with men and boys to changes of social norms and reduction of inequities in gender relations: a conceptual shift in prevention of violence against women and girlsRachel Jewkes, Michael Flood, James Lang
Plos One|May 26, 2012
Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesisBhavna Kumar, Arti Yadav, James Lang, et al.
New Directions for Youth Development|December 23, 2014
4-H Healthy Living programs with impact: a national environmental scanLaura H Downey, Donna J Peterson, Suzanne LeMenestrel, et al.
Molecular Cancer Therapeutics|September 14, 2019
Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary ChemopreventionSusan R Mallery, Daren Wang, Brian Santiago, et al.
Polymers|December 10, 2021
What We Are Learning from COVID-19 for Respiratory Protection: Contemporary and Emerging IssuesRui Li, Mengying Zhang, Yulin Wu, et al.
The American Journal of Managed Care|June 15, 2012
Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providersBruce A Feinberg, James Lang, James Grzegorczyk, et al.
Journal of Oncology Practice|September 4, 2012
Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providersBruce A Feinberg, James Lang, James Grzegorczyk, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 29, 2020
Long-term Effects of Calcium β-Hydroxy-β-Methylbutyrate and Vitamin D3 Supplementation on Muscular Function in Older Adults With and Without Resistance Training: A Randomized, Double-blind, Controlled StudyJohn A Rathmacher, Lisa M Pitchford, Paul Khoo, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 30, 2016
Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic PhenotypeSusan R Mallery, Daren Wang, Brian Santiago, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2010
Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)Eric H Kraut, Christopher Rhoades, Yilong Zhang, et al.
Pageof 2